Komori
Treasury Stock6090Human Metabolome Technologies,Inc.Information and Communications, Services and Others

Notice Regarding the Status of Share Repurchases

From 1 June to 30 June 2025, the Company acquired 43,300 common shares through market purchases. The total acquisition cost was ¥35,145,700, bringing cumulative acquisitions based on a resolution of the Board of Directors to 227,500 shares and ¥166,418,900.

Worth reading
57In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
43300
Shares
Wording
Definitive
How definitive the wording is.

Progress against acquisition limit

Market purchases on the Tokyo Stock Exchange

Resolved 14 May 2025 / Acquisition period 2025年2月14日~2025年12月31日

75.8%
Cumulative utilization rate
Limit72,500 株 remaining
Number of Shares300,000 shares (maximum)
66.6%
Cumulative utilization rate
LimitShares 75.8%83,581,100 円 remaining
Amount2億50百万円(上限)
42.5%
経過
Deadline184 days remaining
Period2025年2月14日~2025年12月31日

The darker band is the portion acquired this time (2025年6月1日から2025年6月30日(約定ベース)). At this pace, the share-count limit will be reached first, and the acquisition will end without using the full monetary limit.

Number of Shares
Limit300,000 shares (maximum)
Cumulative total227,500 株(2025年6月30日時点)
Current43,300 shares
Amount
Limit2億50百万円(上限)
Cumulative total166,418,900 円(2025年6月30日時点)
Current35,145,700 円
Percentage of total issued shares5.1% (as a percentage of the total number of issued shares excluding treasury shares)
Average acquisition price for this transaction (calculated)¥812 per shareCurrent acquisition price ÷ current number of shares acquired

消化率と残りは、会社が示した累計・今回と上限から算出しています。進捗率=上限に対してどこまで使ったかの割合です。 Elapsed time is counted against the acquisition period set in the resolution, as of 06/30/2025. 約定ベース=売買が成立した日を基準に数えた数字です。受け渡しの日ではありません。

Progress against acquisition limit
ItemDetails
Total number of shares acquired in this transaction43,300 shares
Total current acquisition price35,145,700 円
Acquisition date/acquisition period2025年6月1日から2025年6月30日(約定ベース)
Method of acquisitionMarket purchases on the Tokyo Stock Exchange
Cumulative number of shares acquired227,500 株(2025年6月30日時点)
Cumulative acquisition cost166,418,900 円(2025年6月30日時点)
Resolution date14 May 2025
Maximum number of shares to be acquired300,000 shares (maximum)
Total acquisition price2億50百万円(上限)
Acquisition period under the resolution2025年2月14日~2025年12月31日
Percentage of total issued shares5.1% (as a percentage of the total number of issued shares excluding treasury shares)
Items this document does not state (2)
Whether acquisition has been completedAverage Acquisition Price

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

会社法第165条第2項の規定による定款の定めに基づく自己株式の取得であることが示されているが、取得目的の具体的な理由は記載されていない。

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding the Status of Share Repurchases | Human Metabolome Technologies,Inc. (6090) timely disclosure | Komori